Coronavirus: Thread

[grarpamp]

GovCorpPol Scam: Paxlovir which is just a combination of two
pre-existing drugs in one package priced to bankrupt... does nothing.


Pfizer's Paxlovid Shows No Benefit In Younger Adults

https://www.washingtonpost.com/health/study-pfizer-covid-pill-showed-no-benefit-in-younger-adults/2022/08/24/2378c942-23f0-11ed-a72f-1e7149072fbc_story.html
https://www.independent.co.uk/news/world/americas/jill-biden-covid-paxlovid-rebound-rate-b2152470.html
https://www.managedhealthcareexecutive.com/view/paxlovid-rebound-rare-but-real

Pfizer's Covid-19 pill, which President Biden, First Lady Jill Biden
and Dr. Anthony Fauci all experienced "rare" rebound cases after
taking, provides 'little or no benefit for younger adults,' according
to the Washington Post, citing an Israeli study published in the New
England Journal of Medicine.

    The results from a 109,000-patient Israeli study are likely to
renew questions about the U.S. government’s use of Paxlovid, which has
become the go-to treatment for COVID-19 due to its at-home
convenience. The Biden administration has spent more than $10 billion
purchasing the drug and making it available at thousands of pharmacies
through its test-and-treat initiative.

Researchers found that while the drug reduced hospitalizations among
those aged 65 and older by around 75% when taken shortly after
infection, those aged between 40 and 65 saw no measurable benefit.

    PFIZER COVID PILL SHOWS LITTLE, NO BENEFIT FOR YOUNG ADULTS: AP

    But huge benefit for yacht makers
    — zerohedge (@zerohedge) August 24, 2022

"Paxlovid will remain important for people at the highest risk of
severe COVID-19, such as seniors and those with compromised immune
systems," said Dr. David Boulware, a University of Minnesota
researcher and physician. "But for the vast majority of Americans who
are now eligible, this really doesn’t have a lot of benefit."

The FDA authorized Paxlovid late last year for adults and children 12
and older who are considered high risk - which includes the obese,
diabetics, and those with heart disease. Over 42% of US adults are
considered obese - around 138 million people, according to the CDC.

Earlier this summer, Pfizer acknowledged that an independent study of
Paxlovid showed no significant benefit in healthy adults - vaccinated
or not.

Just under 4 million prescriptions of the 5-day treatment have been
filled since it was authorized, according to federal records.

On Wednesday, White House spokesman Kevin Munoz did damage control for
Pfizer - telling the Post in an email that Paxlovid helps reduce
hospitalizations in people 50 and older according to several recent
non-peer-reviewed papers.

"Risk for severe outcomes from COVID is along a gradient, and the
growing body of evidence is showing that individuals between the ages
of 50 and 64 can also benefit from Paxlovid," said Munoz.